MedTrace Logo

Budesonide Nasal Irrigation Versus Fluticasone Propionate Nasal Spray in Treating Allergic Rhinitis Patients

NCT06858423 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 360

Last updated 2025-03-05

No results posted yet for this study

Summary

Budesonide is a medication of the corticosteroid type. Available as an inhaler, nebulization solution, The inhaled form is used in the long-term management of asthma and chronic obstructive pulmonary disease is used for allergic rhinitis and nasal polyps fluticasone propionate

Conditions

  • Nasal Allergy

Interventions

DRUG

Budesonide buffered with 0.9% isotonic saline.

120 patients received budesonide buffered with 0.9% isotonic saline.

DRUG

Fluticasone propionate nasal spray.

120 patients received fluticasone propionate nasal spray.

OTHER

0.9% saline for nasal irrigation.

120 patients used 0.9% saline for nasal irrigation.

Sponsors & Collaborators

  • Benha University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-15
Primary Completion
2024-03-31
Completion
2024-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06858423 on ClinicalTrials.gov